Vivaray Hb pro shows 1.5 g/dL mean absolute error in hemoglobin measurement
Handheld device shows promise for quick blood tests
This cross-sectional diagnostic accuracy study evaluated the Vivaray Hb pro device against a calibrated laboratory blood cell counter in 763…
A new handheld device can measure hemoglobin levels quickly without needles, offering a faster way to screen patients in many different sett…
Efgartigimod PH20 SC showed no significant difference versus placebo in primary ITP
Trial Shows Efgartigimod Results for Immune Thrombocytopenia Patients
This Phase 3 randomized controlled trial evaluated efgartigimod PH20 SC in 207 adults with primary immune thrombocytopenia and platelet coun…
A Phase 3 trial found that the drug efgartigimod did not show a significant difference in platelet counts compared to a placebo.
Venetoclax plus intensive chemo yields 63.79% ORR in relapsed/refractory AML meta-analysis
Venetoclax combo shows promise for hard-to-treat leukemia
A meta-analysis of 235 patients with relapsed/refractory AML found that venetoclax combined with intensive chemotherapy achieved a pooled ov…
For patients with relapsed AML, venetoclax plus intensive chemo led to a 64% response rate in a new analysis.
Avatrombopag shows 80.0% response rate and 2.82% thromboembolic event rate in adult immune thrombocytopenia
Blood clot risk with avatrombopag for immune thrombocytopenia: real-world data
This systematic review and meta-analysis evaluates avatrombopag for adult primary immune thrombocytopenia using real-world data. The analysi…
A new analysis finds avatrombopag works well for low platelets, but about 3% of patients had blood clots. Real-world data from 1,000+ adults…
FDA Approves Besremi (interferon alfa-2b) for Polycythemia Vera
FDA approves new treatment for rare blood disorder polycythemia vera
The FDA approved Besremi (interferon alfa-2b) for adults with polycythemia vera. It is administered subcutaneously every two weeks, with dos…
The FDA approved Besremi (interferon alfa-2b) for adults with polycythemia vera, a condition where the body makes too many red blood cells. …
AI-augmented screening improves hereditary hemolytic anemia detection with 92.8% pooled sensitivity
AI tools improve accuracy for screening hereditary blood disorders
This meta-analysis of 133,498 individuals screened for hereditary hemolytic anemia (HHA) carriers found that AI-augmented complete blood cou…
New data shows that adding artificial intelligence to blood tests can better identify people carrying genes for conditions like sickle cell …
Low-dose ATG plus PTCy shows no significant difference in acute GVHD compared to standard regimens
Trial Shows New Treatment Strategy for Leukemia Stem Cell Transplant
This randomized trial of 407 patients with AML or MDS undergoing haploidentical transplant found that low-dose ATG plus PTCy did not signifi…
A new combination of medications may help patients recover blood cells faster after a stem cell transplant for leukemia or blood disorders.
Functional appliances induce significant three-dimensional condylar changes and forward positioning in Class II malocclusion
Functional Appliances Cause Changes in Jaw Joint Structure
This systematic review examines the impact of Twin Block and Herbst functional appliances on condylar morphology and glenoid fossa remodelin…
New research shows that Twin Block and Herbst appliances can change the size and position of the jaw joint during orthodontic treatment.
Acute cellular senescence facilitates tissue repair while chronic accumulation drives intestinal fibrosis in Crohn's disease
Chronic cell aging may drive scarring in Crohn's disease
This systematic review examines the role of cellular senescence in intestinal fibrosis within Crohn's disease. The authors conclude that acu…
New research reveals how the timing of cellular aging determines whether your body heals properly or develops harmful scar tissue.
FDA Approves Argatroban in Sodium Chloride for Thrombosis in HIT and PCI
FDA approves new blood thinner for patients with rare clotting disorder.
The FDA approved argatroban in sodium chloride injection for prophylaxis or treatment of thrombosis in adult patients with heparin-induced t…
The FDA approved Argatroban in Sodium Chloride injection to prevent or treat blood clots in adults with heparin-induced thrombocytopenia (HI…
FDA Approves Hympavzi (marstacimab) for Routine Prophylaxis in Hemophilia A and B Without Inhibitors
FDA approves Hympavzi to prevent bleeding in hemophilia A and B.
The FDA approved Hympavzi (marstacimab) for routine prophylaxis to prevent or reduce bleeding episodes in patients 12 years and older with h…
The FDA approved Hympavzi (marstacimab) to prevent or reduce bleeding episodes in people 12 and older with hemophilia A or B without inhibit…
OTUD7B acts as a context-dependent regulator in various cancers and inflammatory conditions
Protein OTUD7B plays complex roles in cancer and heart health
This systematic review examines the molecular roles of OTUD7B across multiple malignancies and inflammatory models. The findings indicate th…
A protein called OTUD7B acts as a double-edged sword, helping some conditions while fueling the growth of others.